002038 雙鷺藥業
按盤價 
7.600 +0.020 (+0.264%)
7.600 +0.020 (+0.264%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.505 | -1.302 | 7.396 | 4.349 | 8.282 |
| 總資產報酬率 ROA (%) | 2.350 | -1.209 | 6.857 | 4.029 | 7.637 |
| 投入資產回報率 ROIC (%) | 2.438 | -1.276 | 7.277 | 4.290 | 8.190 | 邊際利潤分析 |
| 銷售毛利率 (%) | 61.597 | 67.970 | 81.560 | 85.054 | 84.889 |
| 營業利潤率 (%) | 35.320 | -18.110 | 46.926 | 25.074 | 37.664 |
| 息稅前利潤/營業總收入 (%) | 33.789 | -21.379 | 44.194 | 23.276 | 36.336 |
| 淨利潤/營業總收入 (%) | 30.655 | -11.400 | 40.748 | 21.743 | 34.682 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 10.153 | -29.164 | 54.327 | 73.458 | 55.689 |
| 價值變動淨收益/利潤總額(%) | 88.012 | 119.003 | 51.510 | 38.535 | 45.651 |
| 營業外收支淨額/利潤總額(%) | -1.996 | 10.577 | -2.791 | -1.529 | 0.064 | 償債能力分析 |
| 流動比率 (X) | 12.373 | 8.600 | 7.072 | 6.916 | 7.071 |
| 速動比率 (X) | 10.484 | 7.749 | 6.685 | 6.443 | 6.687 |
| 資產負債率 (%) | 5.440 | 6.663 | 7.450 | 6.750 | 7.538 |
| 帶息債務/全部投入資本 (%) | 0.890 | 0.486 | 0.091 | -0.435 | -0.813 |
| 股東權益/帶息債務 (%) | 10,907.821 | 20,066.410 | 108,232.141 | -22,658.472 | -12,144.326 |
| 股東權益/負債合計 (%) | 1,735.902 | 1,398.808 | 1,240.178 | 1,378.734 | 1,223.188 |
| 利息保障倍數 (X) | -40.223 | 18.970 | -30.320 | -16.394 | -26.884 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 56.901 | 82.703 | 80.077 | 102.567 | 117.306 |
| 存貨周轉天數 (天) | 491.297 | 332.536 | 269.611 | 300.065 | 232.252 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 21/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
